SUMMARY The extent of oxidoreduction of deoxycholic acid in the enterohepatic circulation was studied in seven healthy subjects and seven patients after cholecystectomy. (12,B-3H) Deoxycholic acid was given orally together with (24-'4C) labelled bile acid. The rate of oxidoreduction of the 12a-hydroxyl group of deoxycholic acid was calculated from the decay in ratio between 3H and 14C. In spite of a normal proportion of deoxycholic acid and other secondary bile acids in bile, patients after cholecystectomy had more than two-fold higher degree of oxidoreduction of the 12a-hydroxyl group than healthy controls. The high extent of oxidoreduction is probably because of an increased exposure of the bile acid pool to intestinal bacteria and may have physiological implications.
Bile acids are subjected to extensive microbial biotransformations in the intestine, including deconjugation, 7 ct-dehydroxylation and oxidoreduction.' Portal venous serum from fasting man contains about 10% of monoketonic bile acids.' In the liver reabsorbed bile acids are reconjugated -but not rehydroxylated -and keto groups are reduced, mainly to a-hydroxyl groups.34 Consequently, human bile normally contains only traces of ketonic bile acids whereas they may represent a significant fraction of human faecal bile acids. 5 Some investigations of bile acid metabolism have shown an increase of secondary bile acids, especially deoxycholic acid in the bile of cholecystectomised patients.`' An increased proportion of ketonic bile acids has also been reported.`" Since there are oxidoreductases both in the intestine and in the liver, it is not possible to evaluate the total extent of oxidoreduction of bile acids during the enterohepatic circulation from the above information. '4 We have recently studied the extent of oxidoreduction of the hydroxyl groups in cholic acid and deoxycholic acid during the enterohepatic circulation in healthy man." The degree of oxidoreduction was Accepted for publication 16 January 1989. considerably higher for deoxycholic acid than for cholic acid. In the present work we have studied the extent of oxidoreduction of deoxycholic acid in cholecystectomised patients with use of deoxycholic acid labelled in 1213-position. The 'H-labelled bile acid was given together with the corresponding 24-'4C-labelled bile acid. The rate of oxidoreduction was calculated from the decay in ratio between 'H and 14C. According to the results obtained, cholecystectomised patients have more than two times higher rate of oxidoreduction of deoxycholic acid than healthy controls.
Methods

PATIENTS
The study comprised five healthy men and two healthy women with no signs of liver or intestinal diseases and seven women who had undergone cholecystectomy for cholesterol gall stones at least six months before this study (Table 1) . None of the patients had received antibiotic therapy during the last two months preceding the study and none was on treatment with any medication known to affect plasma or biliary lipid metabolism.
The ethical aspects of the study were approved by the Ethical Committee at Huddinge University Hospital.
MATERIALS
(1213-3H) Deoxycholic acid (specific radioactivity 83x 101 cpm/mg) was synthesised as recently described.`' (24-'4C) Deoxycholic acid (specific radioactivity 220x 106 cpm/mg) was obtained from New England Nuclear (Dreieichenhain, West-Germany). The compounds were purified as methyl esters by thin layer chromatography using system S 11 before use. ' Increased oxidoreduction ofdeoxycholic acid in cholecystectomisedpatients pool spends a greater part of the 24 hours in the intestine, especially the colon, being exposed to the intestinal microflora to a greater extent than normally. An increased proportion of deoxycholic acid after cholecystectomy, however, has not been found in all studies.9`i'" Whether this discrepancy is caused by differences in intestinal microflora and/or dietary intake in the patient groups investigated can presently not be established with certainty.
A new and important finding of the present study was the high oxidoreduction of the 12a-hydroxyl group of deoxycholic acid in cholecystectomised patients, being more than twice as high as in healthy controls. As was discussed in a recent work from our laboratory,'3 the present technique should give a minimum figure for the extent of oxidoreduction for the following reasons: first, there may be an isotope effect in the oxidation of the 12ca-hydroxyl group adjacent to the 12P-3H-label. Second, a transfer of 'H may occur from the labelled bile acid to a cofactor of the 12ct-hydroxysteroid dehydrogenase in the oxidative step and a subsequent utilisation of the same labelled cofactor by the hydroxysteroid dehydrogenase in the reductive step. Such a mechanism would lead to a certain retention in the bile acid in spite of an oxidoreduction. Therefore, we cannot exclude a small underestimation of the oxidoreduction in the present study.
It should be pointed out, that there are also oxidoreductases present in the liver and it might therefore be argued that part of the oxidoreduction of the 12ct-hydroxyl group could occur in the liver. In a previous work we tried to evaluate the relative roles of the liver and intestine by studying the oxidoreduc-tion of (12p-3H)deoxycholic acid in two patients with ileostomy.'-The FCR for the oxidoreduction of the 12ct-hydroxyl group was less than 20% of that obtained in healthy controls. It is thus apparent that the intestine is of major importance for the oxidoreduction of the 12a-hydroxyl group in deoxycholic acid. In cholecystectomised patients there is an increased recycling of bile acids and an increased exposure of the bile acid pool to bacterial metabolism, which may explain the high extent of oxidoreduction of deoxycholic acid, as discussed above.
12-ketolithocholic acid formed from deoxycholic acid by oxidation of the 12a-hydroxyl group may be excreted as such in faeces where it constitutes one of the major bile acids." It may possibly also be reduced to a 3,12- 
